Riskpilot← Back to searchSign inGet full accessBROLINWESTRELL AB
ABActiveOrg 5567263206Erik Dahlbergsallén 15Activities of psychologists and psychotherapists, except medical doctors · NACE 8693Est. 20077 employees
Revenue 2024
SEK 16,4M
-12% vs 2023
EBITDA margin
21.7%
-42% vs 2023
Equity ratio
80.8%
Financial strength
Net profit 2024
SEK -19K
-190% vs 2023
| Revenue | SEK 16,4M | -12% |
| EBITDA | SEK 3,6M | -42% |
| Net profit | SEK -19K | -190% |
| Total assets | SEK 10M | +0% |
| Equity | SEK 8,1M | +0% |
| Employees | 7 | — |
Legal name
BROLINWESTRELL AB
Org number
5567263206
Legal form
Aktiebolag
NACE code
8693 · Activities of psychologists and psychotherapists, except medical doctors
Founded
14 mars 2007
Share capital
SEK 100 000
Employees
7 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna suppleanten externa firmatecknaren Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget skall bedriva ledarksapsutveckling, krishantering och psykoterapi samt därmed förenlig verksamhet.
Address
Erik Dahlbergsallén 15
Email
jonathan@primaarbetsliv.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 14 562 | 7 439 | 14 905 | 14 444 | 16 571 | 18 636 | 16 373 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | 2 071 | 4 127 | 2 794 | 2 723 | 2 055 | 3 771 | 3 314 | 5 645 | 6 158 | 3 561 |
| Depreciation & amort. | −0 | −0 | −35 | −25 | −15 | −42 | −44 | −59 | −57 | −64 |
| EBIT | 2 071 | 4 127 | 2 759 | 2 698 | 2 040 | 3 729 | 3 270 | 5 586 | 6 101 | 3 497 |
| Net financials | −3 | −6 | −1 | −9 | −3 | −4 | — | 12 | 122 | 180 |
| Profit before tax | 2 068 | 4 121 | 2 757 | 2 690 | 2 037 | 3 725 | −18 | −9 | 21 | −19 |
| Tax | −469 | −913 | −621 | −607 | −443 | −802 | −0 | −0 | −0 | −0 |
| Net profit | 1 599 | 3 208 | 2 136 | 2 083 | 1 594 | 2 923 | −18 | −9 | 21 | −19 |
| Item | 2016 | 2017 | 2018 | 2019 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 3 964 | 6 266 | 5 869 | 5 852 | 7 761 | 9 436 | 9 624 | 9 833 | 10 041 | 10 039 |
| Equity | 1 791 | 3 399 | 3 335 | 3 618 | 5 212 | 8 135 | 8 118 | 8 108 | 8 130 | 8 111 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 2 173 | 2 867 | 2 534 | 2 233 | 2 549 | 1 300 | 1 506 | 1 725 | 1 911 | 1 928 |
| Total debt | 2 173 | 2 867 | 2 534 | 2 233 | 2 549 | 1 300 | 1 506 | 1 725 | 1 911 | 1 928 |
EBITDA margin
21.7%
This company
15.8%
Market median
+37% vs market
20162024
Equity ratio
80.8%
This company
38.2%
Market median
+112% vs market
20162024
Return on equity
-0.2%
This company
18.4%
Market median
-101% vs market
20162024
Net profit margin
-0.1%
This company
8.1%
Market median
-101% vs market
20162024
Asset turnover
1.63×
This company
1.12×
Market median
+46% vs market
20162024
Debt / equity
0.24×
This company
0.62×
Market median
+61% vs market
20162024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-07-01 – 2019-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-07-01 – 2019-06-30
- Annual report 2018Filed via Bolagsverket / SCB · Period 2017-07-01 – 2018-06-30
- Annual report 2017Filed via Bolagsverket / SCB · Period 2016-07-01 – 2017-06-30
- Annual report 2016Filed via Bolagsverket / SCB · Period 2015-07-01 – 2016-06-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
LJ Audit | Audit | 2021 | — | — |
MA Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
JM | Audit | 2021 | — | — |
AM Chief Auditor | Chief Auditor | 2025 | — | — |
EK Chief Auditor | Chief Auditor | 2024 | — | — |
LM Chief Executive Officer | Chief Executive Officer | 2021 | — | — |
NM External Signatory | External Signatory | 2021 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2022 | — | — | |
| Chairman | 2021 | — | — | |
| Deputy Board Member | 2021 | — | — | |
| Deputy Board Member | 2021 | — | — | |
| Board of Directors | 2021 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Prima Vård Sverige AB | Company | 100.0% | 100.0% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Nordstjernan AktiebolagNordstjernan Investment ABPrima Vård Sverige AB
BROLINWESTRELL AB (this company)Board members of BROLINWESTRELL AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Johan Rasmusson | Audit | 0 companies |
| Mandus Andreas Frykman | Chief Executive Officer | 0 companies |
| Jan Max Mikael Westrell | Audit | 0 companies |
| Annie M M Pyk Hammarqvist | Chief Auditor | 0 companies |
| Eddie Kevin Blad | Chief Auditor | 0 companies |
| Lars Magnus Brolin | Chief Executive Officer | 0 companies |
| Nina Mikaelsdotter von Garaguly | External Signatory | 0 companies |
| Karl Jonathan Jarl Wellershaus | Deputy Board Member | 0 companies |
| Hugo Lennart Yngve Lewné | Chairman | 0 companies |
| Ingela Lise-Lotte Ivarsson | Deputy Board Member | 0 companies |
| Kurt Inge Kenneth Aronsson | Deputy Board Member | 0 companies |
| Nils Eric Fleming Sjögren | Board of Directors | 0 companies |